FDA Approved: PALYNZIQ — Supplemental Application (BioMarin Pharmaceutical Inc.)

View source ↗

Summary

The FDA approved BioMarin's supplemental application for PALYNZIQ (pegvaliase-pqpz), related to its regulatory action for phenylketonuria.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Phenylketonuria

Drugs mentioned

• PALYNZIQ (PEGVALIASE-PQPZ)

Snippet

SUPPL AP for PALYNZIQ (PEGVALIASE-PQPZ)